Mean steady-state plasma glucagon concentrations were slightly higher in the control group compared to the type 2 diabetes group, primarily due to the control subgroup with obesity having higher steady-state concentrations than the other three subgroups. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.